Plasma cannabinoid pharmacokinetics after controlled smoking and Ad libitum cannabis smoking in chronic frequent users

Journal of Analytical Toxicology

Volumn 39, Issue 8, 2015, Pages 580-587

  Lee, Dayong ^a   Bergamaschi, Mateus M ^a,b   Milman, Garry ^a   Barnes, Allan J ^a   Queiroz, Regina H C ^b   Vandrey, Ryan ^c   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 HYDROXYDRONABINOL; 9 TETRAHYDROCANNABINOL; CANNABINOID; DRONABINOL; TETRAHYDROCANNABINOLIC ACID; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY BURDEN; CANNABIS SMOKING; CLINICAL RESEARCH; DRUG BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIMIT OF QUANTITATION; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; MIDDLE AGED; NORMAL HUMAN; SMOKING CESSATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; BODY BURDEN; CANNABINOIDS; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; MIDDLE AGED;

EID: 84943744391     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkv082     Document Type: Article

References (45)

1. United Nations Office on Drugs and Crime. (2014) World Drug Report 2014. United Nations Publication, Sales No. E.14.Xi.7. https://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf (accessed Oct 2, 2014).
2. Substance Abuse and Mental Health Services Administration. (2014) Results from the 2013 National Survey on Drug Use and Health:Summary of National Findings and Detailed Tables. NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD.
3. Hartman, R.L., Huestis, M.A. (2013) Cannabis effects on driving skills. Clinical Chemistry, 59, 478-492.
4. Berning, A., Compton, R., Wochinger, K. (2015) Results of the 2013-2014 National Roadside Survey of alcohol and drug use by drivers (traffic safety facts research note. Report No. DOT HS 812 118). National Highway Traffic Safety Administration, Washington, DC.
5. Lacey, J.H., Kelley-Baker, T., Romano, E., Brainard, K., Ramirez, A. (2012) Results of the 2012 California Roadside Survey of nighttime weekend drivers' alcohol and drug use. Pacific Institute for Research and Evaluation, Calverton, MD.
6. Jones, R.K., Shinar, D., Walsh, J.M. (2003) State of knowledge of drug-impaired driving. DTNH 22-98-D-25079, DOT HS 809 642. National Highway Traffic Safety Administration, Washington, DC, pp. 1-120.
7. Johansson, E., Agurell, S., Hollister, L.E., Halldin, M.M. (1988) Prolonged apparent half-life of delta-1-tetrahydrocannabinol in plasma of chronic marijuana users. Journal of Pharmacy and Pharmacology, 40, 374-375.
8. Bornheim, L.M., Lasker, J.M., Raucy, J.L. (1992) Human hepatic microsomal metabolism of delta-1-tetrahydrocannabinol. Drug Metabolism and Disposition, 20, 241-246.
9. Schwope, D.M., Karschner, E.L., Gorelick, D.A., Huestis, M.A. (2011) Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clinical Chemistry, 57, 1406-1414.
10. Milman, G., Bergamaschi, M.M., Lee, D., Mendu, D.R., Barnes, A.J., Vandrey, R. et al. (2014) Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence. Therapeutic Drug Monitoring, 36, 218-224.
11. Vandrey, R., Stitzer, M.L., Mintzer, M.Z., Huestis, M.A., Murray, J.A., Lee, D. (2013) The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug and Alcohol Dependence, 128, 64-70.
12. Lowe, R.H., Karschner, E.L., Schwilke, E.W., Barnes, A.J., Huestis, M.A. (2007) Simultaneous quantification of delta-9-tetrahydrocannabinol (THC), 11-hydroxy-delta-9-tetrahydrocannabinol (11-OH-THC), and 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. Journal of Chromatography A, 1163, 318-327.
13. Ramaekers, J.G., Moeller, M.R., van Ruitenbeek, P., Theunissen, E.L., Schneider, E., Kauert, G. (2006) Cognition and motor control as a function of delta9-THC concentration in serum and oral fluid: limits of impairment. Drug and Alcohol Dependence, 85, 114-122.
14. Drummer, O.H., Gerostamoulos, J., Batziris, H., Chu, M., Caplehorn, J., Robertson, M.D. et al. (2004) The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accident Analysis and Prevention, 36, 239-248.
15. Karschner, E.L., Schwilke, E.W., Lowe, R.H., Darwin, W.D., Pope, H.G., Herning, R. et al. (2009) Do delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction, 104, 2041-2048.
16. Huestis, M.A., Henningfield, J.E., Cone, E.J. (1992) Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. Journal of Analytical Toxicology, 16, 276-282.
17. Ramaekers, J.G., Berghaus, G., van Laar, M., Drummer, O.H. (2004) Dose related risk of motor vehicle crashes after cannabis use. Drug and Alcohol Dependence, 73, 109-119.
18. Mura, P., Kintz, P., Ludes, B., Gaulier, J.M.,Marquet, P.,Martin-Dupont, S. et al. (2003) Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Science International, 133, 79-85.
19. Laumon, B., Gadegbeku, B., Martin, J.L., Biecheler, M.B. (2005) Cannabis intoxication and fatal road crashes in France: population based case-control study. BMJ, 331, 1371.
20. Wolff, K., Johnston, A. (2014) Cannabis use: a perspective in relation to the proposed UK drug-driving legislation. Drug Testing and Analysis, 6, 143-154.
21. Asbridge, M., Poulin, C., Donato, A. (2005) Motor vehicle collision risk and driving under the influence of cannabis: evidence from adolescents in Atlantic Canada. Accident Analysis and Prevention, 37, 1025-1034.
22. Augsburger, M., Donzé, N., Ménétrey, A., Brossard, C., Sporkert, F., Giroud, C. et al. (2005) Concentration of drugs in blood of suspected impaired drivers. Forensic Science International, 153, 11-15.
23. Jones, A.W., Holmgren, A., Kugelberg, F.C. (2008) Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood. Addiction, 103, 452-461.
24. Blencowe, T., Pehrsson, A., Mykkänen, S., Gunnar, T., Lillsunde, P. (2012) Cannabis findings in drivers suspected of driving under the influence of drugs in Finland from 2006 to 2008. Forensic Science International, 217, 107-112.
25. Couper, F.J., Peterson, B.L. (2014) The prevalence of marijuana in suspected impaired driving cases in Washington state. Journal of Analytical Toxicology, 38, 569-574.
26. Urfer, S., Morton, J., Beall, V., Feldmann, J., Gunesch, J. (2014) Analysis of d9-tetrahydrocannabinol driving under the influence of drugs cases in Colorado from January 2011 to February 2014. Journal of Analytical Toxicology, 38, 575-581.
27. Desrosiers, N.A., Himes, S.K., Scheidweiler, K.B., Concheiro-Guisan, M., Gorelick, D.A., Huestis, M.A. (2014) Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clinical Chemistry, 60, 631-643.
28. Huestis, M.A. (2007) Human cannabinoid pharmacokinetics. Chemistry and Biodiversity, 4, 1770-1804.
29. Karschner, E., Schwilke, E., Lowe, R., Darwin,W.D., Herning, R., Cadet, J. et al. (2009) Implications of plasma delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. Journal of Analytical Toxicology, 33, 469-477.
30. Bergamaschi, M.M., Karschner, E.L., Goodwin, R.S., Scheidweiler, K.B., Hirvonen, J., Queiroz, R.H. et al. (2013) Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws. Clinical Chemistry, 59, 519-526.
31. Schwilke, E.W., Karschner, E.L., Lowe, R.H., Gordon, A.M., Cadet, J.L., Herning, R. et al. (2009) Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. Clinical Chemistry, 55, 1188-1195.
32. Brunet, B., Doucet, C., Venisse, N., Hauet, T., Hebrard,W., Papet, Y. et al. (2006) Validation of largewhite pig as an animalmodel for the study of cannabinoids metabolism: application to the study of THC distribution in tissues. Forensic Science International, 161, 169-174.
33. Mura, P., Kintz, P., Dumestre, V., Raul, S., Hauet, T. (2005) THC can be detected in brain while absent in blood. Journal of Analytical Toxicology, 29, 842-843.
34. Eldreth, D.A., Matochik, J.A., Cadet, J.L., Bolla, K.I. (2004) Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. NeuroImage, 23, 914-920.
35. Pope, H.G., Jr, Gruber, A.J., Hudson, J.I., Huestis, M.A., Yurgelun-Todd, D. (2001) Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry, 58, 909-915.
36. Bolla, K.I., Brown, K., Eldreth, D., Tate, K., Cadet, J.L. (2002) Dose-related neurocognitive effects of marijuana use. Neurology, 59, 1337-1343.
37. Solowij, N., Stephens, R.S., Roffman, R.A., Babor, T., Kadden, R., Miller, M. et al. (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA, 287, 1123-1131.
38. Bosker, W.M., Karschner, E.L., Lee, D., Goodwin, R.S., Hirvonen, J., Innis, R.B. et al. (2013) Psychomotor function in chronic daily cannabis smokers during sustained abstinence. PLoS ONE, 8, e53127.
39. Hirvonen, J., Goodwin, R.S., Li, C.T., Terry, G.E., Zoghbi, S.S., Morse, C. et al. (2012) Reversible and regionally selective downregulation of brain cannabinoid CB(1) receptors in chronic daily cannabis smokers. Molecular Psychiatry, 17, 642-649.
40. Schwope, D.M., Bosker,W.M., Ramaekers, J.G., Gorelick, D.A., Huestis, M.A. (2012) Psychomotor performance, subjective and physiological effects and whole blood delta(9)-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. Journal of Analytical Toxicology, 36, 405-412.
41. Ramaekers, J., Theunissen, E., de Brouwer, M., Toennes, S., Moeller, M., Kauert, G. (2011) Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology (Berlin), 214, 391-401.
42. Haney, M., Comer, S.D.,Ward, A.S., Foltin, R.W., Fischman, M.W. (1997) Factors influencing marijuana self-administration by humans. Behavioural Pharmacology, 8, 101-112.
43. Gorelick, D.A., Goodwin, R.S., Schwilke, E., Schwope, D.M., Darwin, W.D., Kelly, D.L. et al. (2011) Antagonist-elicited cannabis withdrawal in humans. Journal of Clinical Psychopharmacology, 31, 603-612.
44. Ramaekers, J.G., Kauert, G., Theunissen, E.L., Toennes, S.W., Moeller, M.R. (2009) Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. Journal of Psychopharmacology, 23, 266-277.
45. Desrosiers, N.A., Ramaekers, J.G., Chauchard, E., Gorelick, D.A., Huestis, M.A. (2015) Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers. Journal of Analytical Toxicology, 39, 251-261.